FDA Approves Ibalizumab for Multidrug-Resistant HIV-1 FDA Approves Ibalizumab for Multidrug-Resistant HIV-1

The FDA has approved ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for the treatment of adults with multidrug-resistant HIV-1.FDA Approvals

Source: Medscape Medical News Headlines - March 6, 2018 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news